Overall aberrant expression of CRLF2 was found in 12.5 % to 15 % of B-ALL that lacks typical chromosomal rearrangements, but was not overexpressed in B-ALL cases that have recurring rearrangements or in other lymphoid malignancies [40–43]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.